Literature DB >> 460953

An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens.

L R Ashdown.   

Abstract

A selective medium consisting of trypticase soy agar with 4% glycerol, 5 mg/l crystal violet, 50 mg/l neutral red and 4 mg/l of gentamicin was devised for isolation of Pseudomonas pseudomallei from clinical specimens. Absorption of neutral red was found to be suitable for differentiating this organism from other bacteria, while gentamicin was effective in selecting Ps. pseudomallei from organisms commonly found in clinical material. The medium was more suitable for screening clinical specimens than MacConkey's agar with colistin-S because it was more selective and allowed multiple specimens to be inoculated on a single plate. Eight thousand clinical specimens from an area endemic for melioidosis were screened on the selective medium. This resulted in the recovery of 8 isolates of Ps. pseudomallei that would not have been detected using routine culture media alone.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 460953     DOI: 10.3109/00313027909061954

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  86 in total

1.  Value of throat swab in diagnosis of melioidosis.

Authors:  V Wuthiekanun; Y Suputtamongkol; A J Simpson; P Kanaphun; N J White
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Effects of soil pH, temperature and water content on the growth of Burkholderia pseudomallei.

Authors:  Y S Chen; S C Chen; C M Kao; Y L Chen
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

3.  Rapid Filter-Based Detection and Culture of Burkholderia pseudomallei from Small Volumes of Urine.

Authors:  Pierre A Michel; Christine Lascols; Jay E Gee; Linda M Weigel; David Sue
Journal:  J Clin Microbiol       Date:  2017-06-21       Impact factor: 5.948

4.  Pathogenicity of high-dose enteral inoculation of Burkholderia pseudomallei to mice.

Authors:  T Eoin West; Nicolle D Myers; Direk Limmathurotsakul; H Denny Liggitt; Narisara Chantratita; Sharon J Peacock; Shawn J Skerrett
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

5.  Comparison of Ashdown's medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomallei.

Authors:  Sharon J Peacock; Grace Chieng; Allen C Cheng; David A B Dance; Premjit Amornchai; Gumphol Wongsuvan; Nittaya Teerawattanasook; Wirongrong Chierakul; Nicholas P J Day; Vanaporn Wuthiekanun
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

6.  Role of selective and nonselective media for isolation of Burkholderia pseudomallei from throat swabs of patients with melioidosis.

Authors:  Allen C Cheng; Vanaporn Wuthiekanun; Direk Limmathurosakul; Gumphol Wongsuvan; Nicholas P J Day; Sharon J Peacock
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

7.  Arabinose assimilation defines a nonvirulent biotype of Burkholderia pseudomallei.

Authors:  M D Smith; B J Angus; V Wuthiekanun; N J White
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

8.  Novel selective medium for isolation of Burkholderia pseudomallei.

Authors:  K Howard; T J J Inglis
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

Review 9.  Antibiotic resistance in Burkholderia species.

Authors:  Katherine A Rhodes; Herbert P Schweizer
Journal:  Drug Resist Updat       Date:  2016-07-30       Impact factor: 18.500

10.  Latex agglutination test for identification of Pseudomonas pseudomallei.

Authors:  M D Smith; V Wuthiekanun; A L Walsh; T L Pitt
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.